Flector FDA Approval History
FDA Approved: Yes (First approved January 31, 2007)
Brand name: Flector
Generic name: diclofenac epolamine
Dosage form: Topical Patch
Company: Institut Biochimique SA
Treatment for: Pain
Flector is a transdermal patch formulation of the nonsteroidal anti-inflammatory drug diclofenac, indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions.
Development Timeline for Flector
|Jan 31, 2007||ApprovalFlector Approved - Institut Biochimique SA - Treatment for acute pain due to minor strains, sprains, and contusions.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.